Skip to main
GRDN

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Service is positioned for significant growth due to its differentiated technology capabilities, strong financial flexibility, and robust M&A pipeline. The company's focus on customer service and relationships, along with its expansion into the assisted living and behavioral health markets, provide opportunities for organic growth. With an attractive offering for all stakeholders and potential for market consolidation, we rate GRDN as a Buy with a price target of $47, based on a 2027 adjusted EBITDA multiple in line with the current 2026 multiple.

Bears say

Guardian Pharmacy Service is facing strong competition within their industry and may struggle to gain market share. Additionally, potential regulatory or reimbursement changes and the company's reliance on technology assets could pose risks to their growth and profitability. This, coupled with potential challenges in relationship management with LTCFs and disruptions in their supply chain, may hinder the company's success and lead to a negative outlook for their stock.

GRDN has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Strong Buy based on their latest research and market trends.

According to 5 analysts, GRDN has a Strong Buy consensus rating as of Aug 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.